CME Program Detail

Title: The 14th Annual Neonatal Symposium
Date: Thu, Oct 24th, 2019
Time: 8:00 am - 12:45 pm
Location: Lang Auditorium

Statement of Need:
The Neonatal Symposium brings together respected leaders in newborn medicine to present critical issues confronting providers of state-of-the-science care to medically fragile, low
birth weight preterm infants. Presentations will include important evidence-based updates in neonatal medicine highlighting the following: current research and guidelines for the management of Transfusion Related Acute Gut Injury (TRAGI); therapeutic hypothermia in the management of Neonatal Encephalopathy; assessment and stabilization of Critical CHD; and management of Bronchopulmonary Dysplasia. Participants will have the opportunity to review current treatment options in order to further optimize neonatal outcomes.

Target Audience:
Neonatologists, pediatricians, obstetricians, neonatal nurse practitioners, neonatal nurses, OB physician assistants, neonatal physician assistants


Edmund F. La Gamma, M.D., FAAP
Professor of Pediatrics, Biochemistry & Molecular Biology, New York Medical College
Chief, Division of Newborn Medicine
Director of the Regional Neonatal Center
Director, Neonatal-Perinatal Fellowship Program
Maria Fareri Children's Hospital, Westchester Medical Center

Sherrie M. Hauft, M.D.
Professor of Clinical Pediatrics, Weill Cornell Medicine
Attending Physician, Division of Newborn Medicine
NewYork-Presbyterian/Komansky Children’s Hospital at Weill Cornell Medical Center

Ganga Krishnamurthy, M.D.
Garrett Isaac Neubauer Associate Professor of Pediatrics
Columbia Vagelos College of Physicians & Surgeons
Medical Director, Milstein Family Infant Cardiac Unit
NewYork-Presbyterian/Columbia University Irving Medical Center

P. Brian Smith, M.D., MPH, MHS
Samuel L. Katz Professor of Pediatrics, Division of Neonatology
Duke University School of Medicine
Chief, Division of Quantitative Sciences
Duke Clinical Research Institute
Disclosures: None


Pinchi S. Srinivasan, M.D., MBA, FAAP and Michael D. Brandler, M.D., FAAP


1. Describe the differences between red cell mass and hematocrit in assessing adequacy of oxygen delivery to meet the level of oxygen consumption in neonates.
2. Explain the role of various physiologic mediators of intestinal blood flow in preterm neonates and how they are affected by RBC storage lesion after PRBC transfusion.
3. Specify the signs and symptoms of abnormal neurological function present in the first few days of life indicating Neonatal Encephalopathy.
4. Review recommendations/guidelines for assessment and stabilization of infants evaluated for therapeutic hypothermia.
5. Describe referral center management options and possible outcomes after treatment.
6. Specify the various CHD that can present in the newborn.
7. Discuss algorithm and work-up of CHD in the neonate.
8. Delineate the delivery room management of critical CHD.
9. Review evidence for the efficacy of furosemide for prevention of BPD.
10. Discuss special considerations for furosemide use in NICU.
11. Describe ongoing clinical studies of furosemide for prevention of BPD.


8:00-8:45 a.m.
Registration & Continental Breakfast

8:45-9:00 a.m.
Welcome/Introductory Remarks
Jaclyn A. Mucaria, MPA
President, NewYork-Presbyterian Queens

Amir Jaffer, MD, MBA
Chief Medical Officer, NewYork-Presbyterian Queens

Joseph J. Abularrage, MD, MPH, M.Phil, FAAP
Chairman, Department of Pediatrics, NewYork-Presbyterian Queens
Professor of Clinical Pediatrics; Assistant Dean (NewYork-Presbyterian Queens)
Liaison for Curricular Projects, Office of Academic Affairs, Weill Cornell Medicine

Symposium Co-Chairs
Pinchi S. Srinivasan, MD, MBA, FAAP
Associate Professor of Clinical Pediatrics, Weill Cornell Medicine
Director of Neonatology, NewYork-Presbyterian Queens

Michael D. Brandler, MD, FAAP
Assistant Professor of Clinical Pediatrics, Weill Cornell Medicine
Associate Director of Neonatology, NewYork-Presbyterian Queens

9:00-9:45 a.m.
Transfusion Related Acute Gut Injury (TRAGI): Evidence, Mechanisms, Current Research and Transfusion Guidelines
Edmund F. La Gamma, MD, FAAP

9:45-10:30 a.m.
Congenital Heart Disease: Nuts and Bolts for the NICU Practitioner
Ganga Krishnamurthy, MD

10:30-10:40 a.m.
Question and Answer Period

10:40-10:55 a.m.

10:55-11:40 a.m.
Current Practices in Therapeutic Hypothermia for Neonatal Encephalopathy
Sherrie M. Hauft, MD

11:40-12:25 p.m.
Furosemide Use for Prevention of Bronchopulmonary Dysplasia (BPD) in Premature Infants
P. Brian Smith, MD, MPH, MHS

12:25-12:35 p.m.
Question and Answer Period

12:35-12:45 p.m.
Closing Remarks

NewYork Presbyterian/Queens is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.

NewYork Presbyterian/Queens designates this Live Activity for a maximum of 3.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement
The Medical Society of The State of New York relies upon planners and faculty participants in its CME activities to provide educational information that is objective and free of bias. In this spirit and in accordance with the guidelines of MSSNY, CPME and the ACCME, all speakers and planners for CME activities must disclose any relevant financial relationships with commercial interests whose products, devices or services may be discussed in the content of a CME activity, that might be perceived as a real or apparent conflict of interest. Any discussion of investigational or unlabeled uses of a product will be identified.

<< Back to Programs List

<< Back to Program Archive